Penetration and efficacy of VEGF siRNA using polyelectrolyte complex micelles in a human solid tumor model in-vitro.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Controlled Release

• Publication date

  2009-07-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jconrel.2009.03.009PMID 19306899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of potential biomarkers for thioacetamide-induced hepatotoxicity using siRNA

  2010cited by this paper
• Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells.

  2008cited by this paper
• Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia.

  2008cited by this paper
• Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer.

  2008influential reference
• Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel

  2008cited by this paper
• Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines

  2007cited by this paper
• Interfering with disease: a progress report on siRNA-based therapeutics

  2007cited by this paper
• Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide.

  2007cited by this paper
• Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs.

  2007cited by this paper
• Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels.

  2007cited by this paper
• Drug resistance and the solid tumor microenvironment.

  2007cited by this paper
• Current status of polymeric gene delivery systems.

  2006cited by this paper
• Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma

  2006cited by this paper
• PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.

  2006influential reference
• Drug penetration in solid tumours

  2006cited by this paper
• Exploiting the enhanced permeability and retention effect for tumor targeting.

  2006cited by this paper
• Chemical modification of siRNAs to improve serum stability without loss of efficacy.

  2006cited by this paper
• RNA interference and potential therapeutic applications of short interfering RNAs

  2005cited by this paper
• A Small Interfering RNA Targeting Vascular Endothelial Growth Factor Inhibits Ewing's Sarcoma Growth in a Xenograft Mouse Model

  2005cited by this paper
• Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

  2005cited by this paper
• Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells

  2005cited by this paper
• RNA interference: From gene silencing to gene-specific therapeutics

  2005cited by this paper
• Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

  2005cited by this paper
• Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer.

  2005cited by this paper
• siRNA therapeutics: big potential from small RNAs

  2005cited by this paper
• Short interfering RNAs as a tool for cancer gene therapy

  2005cited by this paper
• In vivo activity of nuclease-resistant siRNAs.

  2004cited by this paper
• A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics

  2004cited by this paper
• RNA interference targeting Fas protects mice from fulminant hepatitis

  2003cited by this paper
• Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures.

  2003cited by this paper
• RNA interference and human disease.

  2003cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery.

  2000cited by this paper
• Effect of therapeutic macromolecules in spheroids.

  2000cited by this paper
• Contribution of three-dimensional culture to cancer research.

  2000cited by this paper
• Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats

  1999cited by this paper
• A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

  1995cited by this paper
• Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing

  1992cited by this paper

• NANOEMULSION AS A DRUG DELIVERY SYSTEM OF ANTICANCER DRUG

  2025cites this paper
• Chitosan-based nanoarchitectures for siRNA delivery in cancer therapy: A review of pre-clinical and clinical importance.

  2024cites this paper
• Micelle-engineered nanoplatforms for precision oncology

  2024cites this paper
• Polymeric-Micelle-Based Delivery Systems for Nucleic Acids

  2023cites this paper
• Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery.

  2023cites this paper
• Multifunctional polymeric micelle-based nucleic acid delivery: Current advances and future perspectives

  2021cites this paper
• Intra-tumoral drug concentration mapping within solid tumor micro-milieu using in-vitro model and doxorubicin as a model drug

  2020cites this paper
• Tumor cellular membrane camouflaged liposomes as a non-invasive vehicle for genes: specific targeting toward homologous gliomas and traversing the blood-brain barrier.

  2020cites this paper
• Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer

  2019cites this paper
• Current Applications of Nanoemulsions in Cancer Therapeutics

  2019cites this paper
• A d-Peptide Ligand of Integrins for Simultaneously Targeting Angiogenic Blood Vasculature and Glioma Cells.

  2018cites this paper
• Polysaccharide-based Nanoparticles for Gene Delivery

  2017cites this paper
• Recent advances in the design, development, and targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy

  2017cites this paper
• ε-Caprolactone-Modified Polyethylenimine as Efficient Nanocarriers for siRNA Delivery in Vivo.

  2016cites this paper
• Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.

  2016cites this paper
• Bottom‐Up Engineering of Well‐Defined 3D Microtissues Using Microplatforms and Biomedical Applications

  2016cites this paper
• Penetration and Silencing Activity of VEGF Dicer Substrate siRNA Vectorized by Chitosan Nanoparticles in Monolayer Culture and a Solid Tumor Model In Vitro for Potential Application in Tumor Therapy

  2016influential citation
• Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.

  2016cites this paper
• Nanomaterials for theranostics: recent advances and future challenges.

  2015cites this paper
• Intratumoral Pharmacokinetics: Challenges to Nanobiomaterials.

  2015cites this paper
• Hybrid Nanomaterial Complexes for Advanced Phage-guided Gene Delivery

  2014cites this paper
• Functional Nanostructures for Effective Delivery of Small Interfering RNA Therapeutics

  2014cites this paper
• Technical Aspects of 3-Dimentional Culture of Mammalian Cells

  2014cites this paper
• Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.

  2014cites this paper
• Polymeric‐Micelle‐Based Nanomedicine for siRNA Delivery

  2013cites this paper
• siRNA delivery: from basics to therapeutic applications.

  2013cites this paper
• Effective tumor treatment by VEGF siRNA complexed with hydrophobic poly(amino acid)-modified polyethylenimine.

  2013cites this paper
• Tissue Distribution and Efficacy of Gold Nanorods Coupled with Laser Induced Photoplasmonic Therapy in Ehrlich Carcinoma Solid Tumor Model

  2013cites this paper
• Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA.

  2012cites this paper
• Polymeric micelles for siRNA delivery

  2012cites this paper
• Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities.

  2012cites this paper
• A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.

  2012cites this paper
• Molecular assemblies for siRNA delivery

  2012cites this paper
• Synergistic anticancer effects achieved by co-delivery of TRAIL and paclitaxel using cationic polymeric micelles.

  2011cites this paper
• Engineering tumor-targeted poly(amidoamine) (PAMAM) dendrimers for improved penetration and cellular delivery of short-interfering RNA (siRNA) through solid tumors

  2011cites this paper
• Self-Assembled and Nanostructured siRNA Delivery Systems

  2011cites this paper
• Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes.

  2010cites this paper
• Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation.

  2010cites this paper
• Design of lipid and polymeric carriers for nucleic acid delivery

  2010cites this paper
• Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.

  2010cites this paper
• Cancer therapy based on nanomaterials and nanocarrier systems

  2010cites this paper
• In vitro silencing effect of chitosan nanoplexes containing siRNA expressing vector targeting VEGF in breast cancer cell lines.

  2010cites this paper
• Intracellular small interfering RNA delivery using genetically engineered double‐stranded RNA binding protein domain

  2009cites this paper
• Intelligent drug delivery systems.

  2009cites this paper